Schedule 13G ownership disclosure

Arcturus Therapeutics Holdings Inc

Common stock, par value $0.001 per share · CUSIP: 03969T109

Event date: 2026-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Sumitomo Mitsui Trust Group, Inc.

    Shares: 1,689,107.00 · Class: 5.9%

  • Amova Asset Management Co., Ltd.

    Shares: 1,689,107.00 · Class: 5.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-26-013368
Form type
SCHEDULE 13G/A
Filer
Arcturus Therapeutics Holdings Inc.
CIK
CIK 1768224
Filed
Oct 29, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub